Post-effective amendment to a registration statement that is not immediately effective upon filing

Revenue (Tables)

v3.3.1.900
Revenue (Tables)
12 Months Ended
Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Revenue from Product Sales

The Company has not generated revenue from product sales. The Company has generated revenue pursuant to (i) license and collaboration agreements, which include upfront payments for licenses or options to obtain licenses, payments for research and development services and milestone payments, and (ii) government grants.

 

     Years ended December 31,  
     2015      2014  

License fees

   $ —         $ 473,039   

Research and development services

     5,593         876,619   

Milestone payments

     2,538,698         3,184,988   

Government grants

     369,200         830,408   

Other Revenues

     18,440         —     
  

 

 

    

 

 

 

Total Revenue

   $ 2,931,931       $ 5,365,054   
  

 

 

    

 

 

 

Balance Sheet Items Related to FP7 Agreement

The following balance sheet items relate to the FP7 agreement:

 

     Years Ended December 31,  
     2015      2014  

Other current assets (receivables from FP7 grant)

   $ 980,936       $ 857,489   

Cash (restricted cash)

   $ 17,302       $ —     

Accounts payable trade

   $ 424,441       $ 325,864